Linked Data API

Show Search Form

Search Results

156915
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department for Business, Innovation and Skills more like this
answering dept id 26 more like this
answering dept short name Business, Innovation and Skills more like this
answering dept sort name Business, Innovation and Skills more like this
hansard heading Bayer more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Business, Innovation and Skills, what meetings (a) he and (b) officials in his Department have had with Bayer plc in the last five years. more like this
tabling member constituency Bolton South East more like this
tabling member printed
Yasmin Qureshi more like this
uin 215405 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-25more like thismore than 2014-11-25
answer text <p>Details of Ministers’ meetings with external organisations are published quarterly on the Gov.uk website:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data" target="_blank">https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data</a></p><p> </p><p> </p><p> </p><p>Information for April – June 2014 is due to be published soon.</p><p> </p><p>Details of meetings with officials are not held centrally and could only be provided at disproportionate cost.</p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-25T13:46:31.563Zmore like thismore than 2014-11-25T13:46:31.563Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3924
label Biography information for Yasmin Qureshi more like this
156994
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Antibiotics more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, with reference to the Government's response to the House of Commons Science and Technology Committee report, Ensuring access to working antimicrobials, Cm, 8919, whether his Department is working on potential alternative pricing and reimbursement mechanisms for novel antibiotics in advance of the conclusion of the O'Neill Review; and what plans he has to explore new funding mechanisms with industry in the interim. more like this
tabling member constituency Scunthorpe more like this
tabling member printed
Nic Dakin more like this
uin 215487 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-25more like thismore than 2014-11-25
answer text <p>As part of the United Kingdom’s antimicrobial resistance strategy, we have been working with industry and with other national and international stakeholders on how best to stimulate the development of new antibiotics, diagnostics and potential business models as well as on research into antimicrobial resistance.</p><p> </p><p> </p><p> </p><p>We will continue to explore what can be done to support antimicrobial diagnostics and drug development pending the announcement by the independent Review on Antimicrobial Resistance of its conclusions.</p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-25T13:22:48.517Zmore like thismore than 2014-11-25T13:22:48.517Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4056
label Biography information for Nic Dakin more like this
156998
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, on what dates since 2 July 2014 he has discussed with charities the use of off-patent drugs for new indications; and what the content of these discussions was. more like this
tabling member constituency North West Leicestershire more like this
tabling member printed
Andrew Bridgen more like this
uin 215396 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-27more like thismore than 2014-11-27
answer text <p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>My Rt. hon. Friend the Secretary of State has had no discussions with charities about the use of off-patent drugs for new indications since 2 July. Officials have had several discussions with the Breast Cancer Campaign covering their views on medicines licences, implementation of National Institute for Health and Care Excellence guidelines and planning the roundtable discussion on adoption of new evidence into clinical practice. There have also been ongoing discussions with Cancer Research UK on the use of aspirin to help prevent certain cancers.</p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-27T17:23:49.943Zmore like thismore than 2014-11-27T17:23:49.943Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4133
label Biography information for Andrew Bridgen more like this
156999
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Transatlantic Trade and Investment Partnership more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, what advice or research his Department has commissioned from external bodies on the potential effects on the NHS of the Transatlantic Trade and Investment Partnership. more like this
tabling member constituency Denton and Reddish more like this
tabling member printed
Andrew Gwynne more like this
uin 215373 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-27more like thismore than 2014-11-27
answer text <p>While the Department has not commissioned research, we continue to work with the Department for Business, Innovation and Skills, key partners and other stakeholders to ensure our publicly stated position is respected.</p><p> </p><p> </p><p> </p><p>We are aware of concerns about the European Union–United States Transatlantic Trade and Investment Partnership (TTIP) currently being negotiated which are misplaced and inaccurate.</p><p> </p><p> </p><p> </p><p>What we can be absolutely clear on is that this Government will not allow TTIP</p><p> </p><p>negotiations to harm the National Health Service, and any assertion that the agreement will undermine the NHS is both irresponsible and false. Our position is supported by statements from both the European and US negotiators.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-27T17:45:56.233Zmore like thismore than 2014-11-27T17:45:56.233Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1506
label Biography information for Andrew Gwynne more like this
157004
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Paracetamol more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, what the cost to the public purse was of prescriptions issued for paracetamol in England in each of the last two years; and if he will make a statement. more like this
tabling member constituency Enfield North more like this
tabling member printed
Nick de Bois more like this
uin 215406 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-25more like thismore than 2014-11-25
answer text <p>Information on the number and net ingredient cost of prescription items for paracetamol<sup>1</sup> dispensed in the community in England is in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Prescription Items</p><p>(000s)</p></td><td><p>Net Ingredient Cost</p><p>(£000s)</p></td></tr><tr><td><p>2012-13</p></td><td><p>21,963.2</p></td><td><p>73,793.9</p></td></tr><tr><td><p>2013-14</p></td><td><p>22,616.5</p></td><td><p>83,146.6</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs</p><p> </p><p><em>Source:</em> Prescription Cost Analysis system provided by the NHS Business Services Authority</p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
grouped question UIN 215407 more like this
question first answered
less than 2014-11-25T17:07:23.74Zmore like thismore than 2014-11-25T17:07:23.74Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4002
label Biography information for Nick de Bois more like this
157005
registered interest false more like this
date remove maximum value filtermore like thismore than 2014-11-20
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Paracetamol more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, how many prescriptions have been issued for paracetamol in England in each of the last two years. more like this
tabling member constituency Enfield North more like this
tabling member printed
Nick de Bois more like this
uin 215407 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-25more like thismore than 2014-11-25
answer text <p>Information on the number and net ingredient cost of prescription items for paracetamol<sup>1</sup> dispensed in the community in England is in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Prescription Items</p><p>(000s)</p></td><td><p>Net Ingredient Cost</p><p>(£000s)</p></td></tr><tr><td><p>2012-13</p></td><td><p>21,963.2</p></td><td><p>73,793.9</p></td></tr><tr><td><p>2013-14</p></td><td><p>22,616.5</p></td><td><p>83,146.6</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs</p><p> </p><p><em>Source:</em> Prescription Cost Analysis system provided by the NHS Business Services Authority</p><p> </p><p> </p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
grouped question UIN 215406 more like this
question first answered
less than 2014-11-25T17:07:23.85Zmore like thismore than 2014-11-25T17:07:23.85Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4002
label Biography information for Nick de Bois more like this
156582
registered interest false more like this
date less than 2014-11-19more like thismore than 2014-11-19
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, if he will commission research on (a) innovative pathways to diagnose cancer earlier and (b) encouraging the use of such pathways in the NHS. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson more like this
uin 215202 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-26more like thismore than 2014-11-26
answer text <p>The Department’s National Institute for Health Research (NIHR) is funding a £2 million five-year programme of research to understand the reasons why cancer diagnosis may be delayed, and to consider new designs for testing for cancer. The programme is a partnership between the Universities of Bristol, Cambridge, Bangor, Durham, Oxford, Exeter, the NIHR and Bristol NHS Clinical Commissioning Group. The programme objectives are to design and test new service pathways to cancer diagnosis which are based on sound medical evidence, make efficient use of resources and take full account of patients' views. The programme ends in June 2015.</p><p> </p><p> </p><p> </p><p>The Department’s Policy Research Programme funds the Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. The unit carries out research to inform the development of policies that promote diagnosis of cancers at an earlier stage than that prevailing at the moment. These might include policies to enhance access to screening and diagnostic facilities, technical innovations in screening and diagnosis, policies to improve public awareness of cancer and cancer symptoms, and to encourage prompt seeking of medical advice for symptoms. The unit is addressing this need with a programme of research carried out in all areas of England in co-operation with screening services, primary and secondary care.</p><p> </p><p> </p><p> </p><p>We take the issue of ensuring rapid access to innovative therapies, including those for cancer, very seriously. This is why we have launched an external review of the pathways for the development, assessment and adoption of innovative medicines and medical technology. This review will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices. It will set out both short and long-term options for action by Government and relevant bodies (including the National Institute for Health and Care Excellence, the Medicines and Healthcare Products Regulatory Agency and NHS England), and mark a major contribution to the policy debate.</p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-26T17:24:19.887Zmore like thismore than 2014-11-26T17:24:19.887Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
156592
registered interest false more like this
date less than 2014-11-19more like thismore than 2014-11-19
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, what studies he has commissioned on the potential benefits of using dogs to establish early signs of cancer in humans. more like this
tabling member constituency East Londonderry more like this
tabling member printed
Mr Gregory Campbell more like this
uin 215220 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-26more like thismore than 2014-11-26
answer text <p>A study of key considerations for the experimental training and evaluation of cancer odour detection dogs has recently been published in the journal <em>BMC Urology</em>. The National Institute for Health Research (NIHR) Research Design Service for the East Midlands participated in this study.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-26T17:20:50.02Zmore like thismore than 2014-11-26T17:20:50.02Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1409
label Biography information for Mr Gregory Campbell more like this
156631
registered interest false more like this
date less than 2014-11-19more like thismore than 2014-11-19
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, what recent assessment he has made of the extent of access on the NHS to new treatments for patients with rarer cancers. more like this
tabling member constituency Hove more like this
tabling member printed
Mike Weatherley more like this
uin 215320 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-26more like thismore than 2014-11-26
answer text <p>The National Institute for Health and Care Excellence has recommended a number of treatments for rarer cancers. In addition, a number of drugs used in rarer cancers are available through the Cancer Drugs Fund administered by NHS England.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-26T17:00:05.477Zmore like thismore than 2014-11-26T17:00:05.477Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
3984
label Biography information for Mike Weatherley more like this
156673
registered interest false more like this
date less than 2014-11-19more like thismore than 2014-11-19
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Mental Health Services: Young People more like this
house id 1 more like this
legislature
25259
pref label House of Commons remove filter
question text To ask the Secretary of State for Health, what research his Department has commissioned on supporting young people moving from children's to adult's mental health services. more like this
tabling member constituency Streatham more like this
tabling member printed
Mr Chuka Umunna more like this
uin 215357 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-11-26more like thismore than 2014-11-26
answer text <p>The National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Cambridgeshire and Peterborough (now the CLAHRC East of England) has funded a range of research on this topic. Details are available on the CLAHRC’s website at:</p><p> </p><p> </p><p> </p><p><a href="http://clahrc-cp.nihr.ac.uk/" target="_blank">http://clahrc-cp.nihr.ac.uk/</a></p><p> </p><p> </p><p> </p><p>Details of outputs from a project on this topic are available on the NIHR Evaluation, Trials and Studies website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nets.nihr.ac.uk/projects/hsdr/081613117" target="_blank">http://www.nets.nihr.ac.uk/projects/hsdr/081613117</a></p><p> </p><p> </p><p> </p><p>The NIHR is currently funding a £2 million programme of research on how health services can contribute most effectively to facilitating successful transition of young people with complex health needs from childhood to adulthood. This programme ends in April 2017.</p><p> </p><p> </p><p> </p><p>The Department’s Policy Research Programme funds the Policy Research Unit in the Health of Children, Young People and Families at University College London. The unit is currently undertaking a research project to explore issues around expanding adolescent and young adult care and movement of transition point to 24 years of age.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman remove filter
question first answered
less than 2014-11-26T17:22:19.703Zmore like thismore than 2014-11-26T17:22:19.703Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
4128
label Biography information for Chuka Umunna more like this